Navigation Links
Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada

MISSISSAUGA, Ontario, June 14, 2011 /PRNewswire/ -- Theramed Corporation ("Theramed") announces that it will launch ebb™ and jetty™ at the 67th Clinical Meeting of the Society of Obstetricians and Gynecologists of Canada. The two newly developed medical devices are to be used to advance the practice of obstetrics, from Glenveigh International, LLC ("Glenveigh"). Both medical device products have been approved for sale by Health Canada, and Theramed will begin distributing these products on June 17th. "We are very excited to partner with Glenveigh Medical in advancing obstetrics for healthy moms and babies in Canada," commented Bill Baugh, Theramed's Chief Executive Officer.

About the ebb™ Complete Tamponade System

ebb™ is a complete tamponade solution for postpartum hemorrhage. Designed by world-renowned maternal-fetal medicine specialists Michael A. Belfort and Gary A. Dildy, the ebb™ balloon is made of a malleable yet extremely strong material, allowing ebb™ to expand and conform to any uterine shape. ebb™ also features a vaginal balloon to control vaginal bleeding and act as an anchor to support the uterine balloon. External ports allow independent control of inflation, deflation, irrigation, and drainage.

About the jetty™ Vaginal Repair Balloon

jetty™ is indicated for use during episiotomy and vaginal laceration repair to temporarily prevent the postpartum discharge of fluids from the vagina in order to assist with the repair procedure. jetty™ provides clarity and cleanliness for a timely, effective repair, and it eliminates the need for vaginal packing with gauze or sponges.

About Theramed Corporation

Theramed Corporation, headquartered in Mississauga, Ontario, is a specialty pharmaceutical company, focused on the development, acquisition, in-licensing, marketing, and distribution of medical products in Canada. The Company is dedicated to bringing new-to-market and well-established healthcare innovations to Canadian Physicians and Hospitals, be these Pharmaceuticals, Biotech products, or Medical Devices. The company currently markets Delatestryl®, Viroptic®, CollatampG® and FSME-IMMUN®.

About Glenveigh International, LLC

Glenveigh is a life science and medical technology company focused on advancing the practice of obstetrics, with aspirations to rapidly become the market leader in the OB/GYN field. Formed in 2004 by a maternal-fetal medicine (MFM) specialist, Glenveigh is founded on the core mission of improving the lives of pregnant mothers and their babies.

For more information on ebb™ or jetty™, marketing medical innovations in Canada, or on Theramed, please contact:

T.W. (Bill) Baugh III
President and CEO
Tel: 905-564-5009 or 800-305-4441

SOURCE Theramed Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
2. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
3. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
4. AmbiCom Forms Joint Alliance With E-Care Technology Corporation
5. Volcano Corporation Presentation at William Blair Conference to be Webcast
6. President of Minntech Corporation Injured in Plane Crash
7. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
8. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
9. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
10. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
11. Statement From Volcano Corporation on Latest St. Jude Lawsuit
Post Your Comments:
(Date:11/30/2015)... 2015 --> --> ... Market by Product (Soft Tissue, All Tissue, Dental Welding Lasers), ... and Geography - Global Forecast to 2020", published by MarketsandMarkets, ... a CAGR of 5.2% during the forecast period from 2015 ... and 62 Figures spread through 167 P ages and ...
(Date:11/30/2015)... INDIANAPOLIS , Nov. 30, 2015  PTS Diagnostics, ... as CardioChek ® analyzers, A1CNow ® systems, ... of a family of patents that will propel the ... and Europe . The ... cameras, such as those on smartphones and tablets, and ...
(Date:11/30/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ), ... oral drug delivery systems, announced today it has signed ... Hefei Tianhui Incubator of Technologies Co., Ltd. ("HTIT") for exclusive ... China , Hong Kong ... agreements were signed at the Israel Knesset (Parliament). ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... the United States to access life-saving information provided directly from top experts ... consist of three individual conferences in three major cities: Houston, San Francisco, and ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... its annual fundraising campaign to raise funds for its research, education, support, and ... of the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also ...
(Date:11/30/2015)... Wilmington, DE (PRWEB) , ... November 30, 2015 ... ... a guest lecturer at a University of Delaware Accounting and Management of Information ... accounting software solutions for mid-market businesses. Sommer will speak at before student in ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Progressive Dental Institute ... January 29 and 30, 2016. The course welcomes dental professionals and members of ... learn how to better succeed in the modern dental marketplace. The course combines ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
Breaking Medicine News(10 mins):